nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—HTR7—coronary artery disease	0.121	0.325	CbGaD
Cabergoline—ADRB1—coronary artery disease	0.103	0.278	CbGaD
Cabergoline—ADRB2—coronary artery disease	0.0868	0.234	CbGaD
Cabergoline—HTR2A—coronary artery disease	0.0606	0.163	CbGaD
Cabergoline—HTR1B—Penbutolol—coronary artery disease	0.0546	0.175	CbGbCtD
Cabergoline—ADRB2—Penbutolol—coronary artery disease	0.0434	0.139	CbGbCtD
Cabergoline—ADRB1—Penbutolol—coronary artery disease	0.0427	0.137	CbGbCtD
Cabergoline—HTR1A—Penbutolol—coronary artery disease	0.0342	0.11	CbGbCtD
Cabergoline—ADRB2—Timolol—coronary artery disease	0.0305	0.0979	CbGbCtD
Cabergoline—ADRB1—Timolol—coronary artery disease	0.0301	0.0965	CbGbCtD
Cabergoline—CYP3A4—Ticagrelor—coronary artery disease	0.0112	0.0359	CbGbCtD
Cabergoline—CYP3A4—Fenofibrate—coronary artery disease	0.00998	0.032	CbGbCtD
Cabergoline—CYP3A4—Gemfibrozil—coronary artery disease	0.00797	0.0256	CbGbCtD
Cabergoline—CYP3A4—Clopidogrel—coronary artery disease	0.00691	0.0222	CbGbCtD
Cabergoline—HTR2B—cardial valve—coronary artery disease	0.0068	0.166	CbGeAlD
Cabergoline—CYP3A4—Eplerenone—coronary artery disease	0.00643	0.0206	CbGbCtD
Cabergoline—CYP3A4—Enalapril—coronary artery disease	0.00573	0.0184	CbGbCtD
Cabergoline—CYP3A4—Ezetimibe—coronary artery disease	0.00446	0.0143	CbGbCtD
Cabergoline—CYP3A4—Rosuvastatin—coronary artery disease	0.00446	0.0143	CbGbCtD
Cabergoline—CYP3A4—Simvastatin—coronary artery disease	0.00414	0.0133	CbGbCtD
Cabergoline—CYP3A4—Lovastatin—coronary artery disease	0.00405	0.013	CbGbCtD
Cabergoline—CYP3A4—Pravastatin—coronary artery disease	0.00405	0.013	CbGbCtD
Cabergoline—CYP3A4—Atorvastatin—coronary artery disease	0.00369	0.0118	CbGbCtD
Cabergoline—CYP3A4—Losartan—coronary artery disease	0.00338	0.0108	CbGbCtD
Cabergoline—HTR7—pulmonary artery—coronary artery disease	0.00236	0.0574	CbGeAlD
Cabergoline—HTR7—sympathetic nervous system—coronary artery disease	0.00229	0.0558	CbGeAlD
Cabergoline—HTR2A—arteriole—coronary artery disease	0.00224	0.0546	CbGeAlD
Cabergoline—HTR7—vagus nerve—coronary artery disease	0.00222	0.0541	CbGeAlD
Cabergoline—HTR7—vein—coronary artery disease	0.00214	0.0522	CbGeAlD
Cabergoline—HTR7—autonomic nervous system—coronary artery disease	0.00154	0.0375	CbGeAlD
Cabergoline—HTR2A—pulmonary artery—coronary artery disease	0.00147	0.0358	CbGeAlD
Cabergoline—HTR2A—sympathetic nervous system—coronary artery disease	0.00143	0.0348	CbGeAlD
Cabergoline—HTR2A—vagus nerve—coronary artery disease	0.00138	0.0337	CbGeAlD
Cabergoline—HTR2A—vein—coronary artery disease	0.00134	0.0326	CbGeAlD
Cabergoline—HTR1B—artery—coronary artery disease	0.00113	0.0276	CbGeAlD
Cabergoline—HTR1D—artery—coronary artery disease	0.0011	0.0267	CbGeAlD
Cabergoline—DRD4—heart—coronary artery disease	0.00102	0.0249	CbGeAlD
Cabergoline—HTR2A—autonomic nervous system—coronary artery disease	0.000961	0.0234	CbGeAlD
Cabergoline—HTR7—artery—coronary artery disease	0.000874	0.0213	CbGeAlD
Cabergoline—HTR7—endothelium—coronary artery disease	0.000738	0.018	CbGeAlD
Cabergoline—ADRB1—cardiac ventricle—coronary artery disease	0.000598	0.0146	CbGeAlD
Cabergoline—ADRB1—myocardium—coronary artery disease	0.000562	0.0137	CbGeAlD
Cabergoline—HTR2A—artery—coronary artery disease	0.000545	0.0133	CbGeAlD
Cabergoline—HTR2A—endothelium—coronary artery disease	0.00046	0.0112	CbGeAlD
Cabergoline—ADRA2C—cardiac ventricle—coronary artery disease	0.00045	0.011	CbGeAlD
Cabergoline—Lisuride—ADRB1—coronary artery disease	0.000441	0.442	CrCbGaD
Cabergoline—ADRA2C—myocardium—coronary artery disease	0.000424	0.0103	CbGeAlD
Cabergoline—HTR1B—cardiovascular system—coronary artery disease	0.000394	0.00959	CbGeAlD
Cabergoline—ADRB1—heart—coronary artery disease	0.000392	0.00956	CbGeAlD
Cabergoline—HTR1D—cardiovascular system—coronary artery disease	0.000381	0.00929	CbGeAlD
Cabergoline—HTR2B—heart—coronary artery disease	0.000376	0.00915	CbGeAlD
Cabergoline—ADRB1—cardiovascular system—coronary artery disease	0.00037	0.00902	CbGeAlD
Cabergoline—HTR2B—cardiovascular system—coronary artery disease	0.000355	0.00864	CbGeAlD
Cabergoline—ADRB1—cardiac atrium—coronary artery disease	0.000336	0.00818	CbGeAlD
Cabergoline—HTR7—heart—coronary artery disease	0.000322	0.00784	CbGeAlD
Cabergoline—HTR1A—cardiovascular system—coronary artery disease	0.000318	0.00774	CbGeAlD
Cabergoline—ADRA1A—heart—coronary artery disease	0.00031	0.00756	CbGeAlD
Cabergoline—HTR7—cardiovascular system—coronary artery disease	0.000304	0.0074	CbGeAlD
Cabergoline—Pergolide—HTR2A—coronary artery disease	0.000298	0.299	CrCbGaD
Cabergoline—ADRA2C—heart—coronary artery disease	0.000296	0.0072	CbGeAlD
Cabergoline—ADRA1A—cardiovascular system—coronary artery disease	0.000293	0.00713	CbGeAlD
Cabergoline—HTR2B—blood—coronary artery disease	0.00028	0.00683	CbGeAlD
Cabergoline—Lisuride—HTR2A—coronary artery disease	0.000259	0.259	CrCbGaD
Cabergoline—ADRA2C—cardiac atrium—coronary artery disease	0.000253	0.00616	CbGeAlD
Cabergoline—HTR7—blood—coronary artery disease	0.00024	0.00585	CbGeAlD
Cabergoline—ADRA2A—heart—coronary artery disease	0.000236	0.00575	CbGeAlD
Cabergoline—ADRA1A—blood—coronary artery disease	0.000232	0.00564	CbGeAlD
Cabergoline—ADRA2C—blood—coronary artery disease	0.000221	0.00538	CbGeAlD
Cabergoline—ADRA2A—cardiac atrium—coronary artery disease	0.000202	0.00492	CbGeAlD
Cabergoline—HTR2A—heart—coronary artery disease	0.000201	0.00489	CbGeAlD
Cabergoline—HTR2A—cardiovascular system—coronary artery disease	0.000189	0.00461	CbGeAlD
Cabergoline—ADRA2A—blood—coronary artery disease	0.000176	0.00429	CbGeAlD
Cabergoline—HTR2A—blood—coronary artery disease	0.00015	0.00365	CbGeAlD
Cabergoline—CYP3A4—blood—coronary artery disease	0.000139	0.00338	CbGeAlD
Cabergoline—Rash—Clopidogrel—coronary artery disease	6.57e-05	0.000424	CcSEcCtD
Cabergoline—Dermatitis—Clopidogrel—coronary artery disease	6.56e-05	0.000424	CcSEcCtD
Cabergoline—Asthenia—Valsartan—coronary artery disease	6.56e-05	0.000424	CcSEcCtD
Cabergoline—Hypertension—Timolol—coronary artery disease	6.55e-05	0.000424	CcSEcCtD
Cabergoline—Pain—Furosemide—coronary artery disease	6.55e-05	0.000423	CcSEcCtD
Cabergoline—Constipation—Furosemide—coronary artery disease	6.55e-05	0.000423	CcSEcCtD
Cabergoline—Hypersensitivity—Niacin—coronary artery disease	6.55e-05	0.000423	CcSEcCtD
Cabergoline—Ill-defined disorder—Lisinopril—coronary artery disease	6.53e-05	0.000422	CcSEcCtD
Cabergoline—Discomfort—Ramipril—coronary artery disease	6.53e-05	0.000422	CcSEcCtD
Cabergoline—Asthenia—Olmesartan—coronary artery disease	6.52e-05	0.000422	CcSEcCtD
Cabergoline—Headache—Clopidogrel—coronary artery disease	6.52e-05	0.000422	CcSEcCtD
Cabergoline—Rash—Lovastatin—coronary artery disease	6.52e-05	0.000422	CcSEcCtD
Cabergoline—Dermatitis—Lovastatin—coronary artery disease	6.52e-05	0.000421	CcSEcCtD
Cabergoline—Dyspepsia—Losartan—coronary artery disease	6.5e-05	0.00042	CcSEcCtD
Cabergoline—Feeling abnormal—Perindopril—coronary artery disease	6.49e-05	0.00042	CcSEcCtD
Cabergoline—Headache—Lovastatin—coronary artery disease	6.48e-05	0.000419	CcSEcCtD
Cabergoline—Pruritus—Valsartan—coronary artery disease	6.46e-05	0.000418	CcSEcCtD
Cabergoline—Dry mouth—Ramipril—coronary artery disease	6.46e-05	0.000418	CcSEcCtD
Cabergoline—Arthralgia—Timolol—coronary artery disease	6.46e-05	0.000418	CcSEcCtD
Cabergoline—Vomiting—Ezetimibe—coronary artery disease	6.45e-05	0.000417	CcSEcCtD
Cabergoline—Hypersensitivity—Pravastatin—coronary artery disease	6.44e-05	0.000417	CcSEcCtD
Cabergoline—Gastrointestinal pain—Perindopril—coronary artery disease	6.44e-05	0.000416	CcSEcCtD
Cabergoline—Anxiety—Timolol—coronary artery disease	6.44e-05	0.000416	CcSEcCtD
Cabergoline—Pruritus—Olmesartan—coronary artery disease	6.43e-05	0.000416	CcSEcCtD
Cabergoline—Decreased appetite—Losartan—coronary artery disease	6.42e-05	0.000415	CcSEcCtD
Cabergoline—Abdominal pain—Captopril—coronary artery disease	6.41e-05	0.000415	CcSEcCtD
Cabergoline—Dizziness—Simvastatin—coronary artery disease	6.4e-05	0.000413	CcSEcCtD
Cabergoline—Rash—Ezetimibe—coronary artery disease	6.4e-05	0.000413	CcSEcCtD
Cabergoline—Dermatitis—Ezetimibe—coronary artery disease	6.39e-05	0.000413	CcSEcCtD
Cabergoline—Confusional state—Ramipril—coronary artery disease	6.39e-05	0.000413	CcSEcCtD
Cabergoline—Discomfort—Timolol—coronary artery disease	6.38e-05	0.000413	CcSEcCtD
Cabergoline—Asthenia—Niacin—coronary artery disease	6.37e-05	0.000412	CcSEcCtD
Cabergoline—Fatigue—Losartan—coronary artery disease	6.37e-05	0.000412	CcSEcCtD
Cabergoline—Headache—Ezetimibe—coronary artery disease	6.36e-05	0.000411	CcSEcCtD
Cabergoline—Malaise—Lisinopril—coronary artery disease	6.35e-05	0.00041	CcSEcCtD
Cabergoline—Oedema—Ramipril—coronary artery disease	6.34e-05	0.00041	CcSEcCtD
Cabergoline—Vertigo—Lisinopril—coronary artery disease	6.33e-05	0.000409	CcSEcCtD
Cabergoline—Dry mouth—Timolol—coronary artery disease	6.32e-05	0.000408	CcSEcCtD
Cabergoline—Pain—Losartan—coronary artery disease	6.32e-05	0.000408	CcSEcCtD
Cabergoline—Constipation—Losartan—coronary artery disease	6.32e-05	0.000408	CcSEcCtD
Cabergoline—Syncope—Lisinopril—coronary artery disease	6.31e-05	0.000408	CcSEcCtD
Cabergoline—Vomiting—Eplerenone—coronary artery disease	6.31e-05	0.000408	CcSEcCtD
Cabergoline—Feeling abnormal—Furosemide—coronary artery disease	6.31e-05	0.000408	CcSEcCtD
Cabergoline—Nausea—Fenofibrate—coronary artery disease	6.29e-05	0.000407	CcSEcCtD
Cabergoline—Pruritus—Niacin—coronary artery disease	6.29e-05	0.000406	CcSEcCtD
Cabergoline—Asthenia—Pravastatin—coronary artery disease	6.28e-05	0.000406	CcSEcCtD
Cabergoline—Gastrointestinal pain—Furosemide—coronary artery disease	6.26e-05	0.000405	CcSEcCtD
Cabergoline—Rash—Eplerenone—coronary artery disease	6.26e-05	0.000405	CcSEcCtD
Cabergoline—Hypersensitivity—Trandolapril—coronary artery disease	6.26e-05	0.000404	CcSEcCtD
Cabergoline—Dermatitis—Eplerenone—coronary artery disease	6.26e-05	0.000404	CcSEcCtD
Cabergoline—Diarrhoea—Valsartan—coronary artery disease	6.25e-05	0.000404	CcSEcCtD
Cabergoline—Confusional state—Timolol—coronary artery disease	6.25e-05	0.000404	CcSEcCtD
Cabergoline—Shock—Ramipril—coronary artery disease	6.23e-05	0.000403	CcSEcCtD
Cabergoline—Hypersensitivity—Enalapril—coronary artery disease	6.23e-05	0.000403	CcSEcCtD
Cabergoline—Abdominal pain—Perindopril—coronary artery disease	6.23e-05	0.000403	CcSEcCtD
Cabergoline—Palpitations—Lisinopril—coronary artery disease	6.22e-05	0.000402	CcSEcCtD
Cabergoline—Diarrhoea—Olmesartan—coronary artery disease	6.22e-05	0.000402	CcSEcCtD
Cabergoline—Headache—Eplerenone—coronary artery disease	6.22e-05	0.000402	CcSEcCtD
Cabergoline—Oedema—Timolol—coronary artery disease	6.19e-05	0.0004	CcSEcCtD
Cabergoline—Pruritus—Pravastatin—coronary artery disease	6.19e-05	0.0004	CcSEcCtD
Cabergoline—Loss of consciousness—Lisinopril—coronary artery disease	6.19e-05	0.0004	CcSEcCtD
Cabergoline—Nausea—Clopidogrel—coronary artery disease	6.19e-05	0.0004	CcSEcCtD
Cabergoline—Vomiting—Simvastatin—coronary artery disease	6.15e-05	0.000398	CcSEcCtD
Cabergoline—Hypersensitivity—Telmisartan—coronary artery disease	6.15e-05	0.000397	CcSEcCtD
Cabergoline—Nausea—Lovastatin—coronary artery disease	6.14e-05	0.000397	CcSEcCtD
Cabergoline—Hyperhidrosis—Ramipril—coronary artery disease	6.13e-05	0.000396	CcSEcCtD
Cabergoline—Rash—Simvastatin—coronary artery disease	6.1e-05	0.000394	CcSEcCtD
Cabergoline—Dermatitis—Simvastatin—coronary artery disease	6.09e-05	0.000394	CcSEcCtD
Cabergoline—Asthenia—Trandolapril—coronary artery disease	6.09e-05	0.000394	CcSEcCtD
Cabergoline—Shock—Timolol—coronary artery disease	6.09e-05	0.000394	CcSEcCtD
Cabergoline—Feeling abnormal—Losartan—coronary artery disease	6.09e-05	0.000394	CcSEcCtD
Cabergoline—Diarrhoea—Niacin—coronary artery disease	6.08e-05	0.000393	CcSEcCtD
Cabergoline—Asthenia—Enalapril—coronary artery disease	6.07e-05	0.000392	CcSEcCtD
Cabergoline—Headache—Simvastatin—coronary artery disease	6.06e-05	0.000392	CcSEcCtD
Cabergoline—Abdominal pain—Furosemide—coronary artery disease	6.05e-05	0.000391	CcSEcCtD
Cabergoline—Gastrointestinal pain—Losartan—coronary artery disease	6.04e-05	0.000391	CcSEcCtD
Cabergoline—Dizziness—Valsartan—coronary artery disease	6.04e-05	0.00039	CcSEcCtD
Cabergoline—Anorexia—Ramipril—coronary artery disease	6.04e-05	0.00039	CcSEcCtD
Cabergoline—Nausea—Ezetimibe—coronary artery disease	6.03e-05	0.000389	CcSEcCtD
Cabergoline—Dizziness—Olmesartan—coronary artery disease	6.01e-05	0.000389	CcSEcCtD
Cabergoline—Pruritus—Trandolapril—coronary artery disease	6.01e-05	0.000388	CcSEcCtD
Cabergoline—Arthralgia—Lisinopril—coronary artery disease	5.99e-05	0.000387	CcSEcCtD
Cabergoline—Hyperhidrosis—Timolol—coronary artery disease	5.99e-05	0.000387	CcSEcCtD
Cabergoline—Asthenia—Telmisartan—coronary artery disease	5.99e-05	0.000387	CcSEcCtD
Cabergoline—Pruritus—Enalapril—coronary artery disease	5.99e-05	0.000387	CcSEcCtD
Cabergoline—Diarrhoea—Pravastatin—coronary artery disease	5.98e-05	0.000387	CcSEcCtD
Cabergoline—Anxiety—Lisinopril—coronary artery disease	5.97e-05	0.000386	CcSEcCtD
Cabergoline—Discomfort—Lisinopril—coronary artery disease	5.92e-05	0.000383	CcSEcCtD
Cabergoline—Hypotension—Ramipril—coronary artery disease	5.92e-05	0.000383	CcSEcCtD
Cabergoline—Anorexia—Timolol—coronary artery disease	5.9e-05	0.000382	CcSEcCtD
Cabergoline—Pruritus—Telmisartan—coronary artery disease	5.9e-05	0.000382	CcSEcCtD
Cabergoline—Nausea—Eplerenone—coronary artery disease	5.9e-05	0.000381	CcSEcCtD
Cabergoline—Dizziness—Niacin—coronary artery disease	5.87e-05	0.00038	CcSEcCtD
Cabergoline—Dry mouth—Lisinopril—coronary artery disease	5.86e-05	0.000379	CcSEcCtD
Cabergoline—Abdominal pain—Losartan—coronary artery disease	5.84e-05	0.000378	CcSEcCtD
Cabergoline—Asthenia—Captopril—coronary artery disease	5.82e-05	0.000376	CcSEcCtD
Cabergoline—Diarrhoea—Trandolapril—coronary artery disease	5.81e-05	0.000376	CcSEcCtD
Cabergoline—Vomiting—Valsartan—coronary artery disease	5.81e-05	0.000375	CcSEcCtD
Cabergoline—Confusional state—Lisinopril—coronary artery disease	5.79e-05	0.000374	CcSEcCtD
Cabergoline—Diarrhoea—Enalapril—coronary artery disease	5.79e-05	0.000374	CcSEcCtD
Cabergoline—Hypotension—Timolol—coronary artery disease	5.79e-05	0.000374	CcSEcCtD
Cabergoline—Dizziness—Pravastatin—coronary artery disease	5.78e-05	0.000374	CcSEcCtD
Cabergoline—Vomiting—Olmesartan—coronary artery disease	5.78e-05	0.000374	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.77e-05	0.000373	CcSEcCtD
Cabergoline—Rash—Valsartan—coronary artery disease	5.76e-05	0.000372	CcSEcCtD
Cabergoline—Dermatitis—Valsartan—coronary artery disease	5.76e-05	0.000372	CcSEcCtD
Cabergoline—Nausea—Simvastatin—coronary artery disease	5.75e-05	0.000371	CcSEcCtD
Cabergoline—Oedema—Lisinopril—coronary artery disease	5.75e-05	0.000371	CcSEcCtD
Cabergoline—Pruritus—Captopril—coronary artery disease	5.74e-05	0.000371	CcSEcCtD
Cabergoline—Rash—Olmesartan—coronary artery disease	5.73e-05	0.000371	CcSEcCtD
Cabergoline—Insomnia—Ramipril—coronary artery disease	5.73e-05	0.00037	CcSEcCtD
Cabergoline—Dermatitis—Olmesartan—coronary artery disease	5.73e-05	0.00037	CcSEcCtD
Cabergoline—Headache—Valsartan—coronary artery disease	5.72e-05	0.00037	CcSEcCtD
Cabergoline—Diarrhoea—Telmisartan—coronary artery disease	5.71e-05	0.000369	CcSEcCtD
Cabergoline—Headache—Olmesartan—coronary artery disease	5.7e-05	0.000368	CcSEcCtD
Cabergoline—Paraesthesia—Ramipril—coronary artery disease	5.69e-05	0.000368	CcSEcCtD
Cabergoline—Shock—Lisinopril—coronary artery disease	5.65e-05	0.000365	CcSEcCtD
Cabergoline—Asthenia—Perindopril—coronary artery disease	5.65e-05	0.000365	CcSEcCtD
Cabergoline—Dyspnoea—Ramipril—coronary artery disease	5.65e-05	0.000365	CcSEcCtD
Cabergoline—Vomiting—Niacin—coronary artery disease	5.65e-05	0.000365	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Timolol—coronary artery disease	5.64e-05	0.000365	CcSEcCtD
Cabergoline—Hypersensitivity—Furosemide—coronary artery disease	5.64e-05	0.000365	CcSEcCtD
Cabergoline—Somnolence—Ramipril—coronary artery disease	5.63e-05	0.000364	CcSEcCtD
Cabergoline—Dizziness—Trandolapril—coronary artery disease	5.62e-05	0.000363	CcSEcCtD
Cabergoline—Insomnia—Timolol—coronary artery disease	5.6e-05	0.000362	CcSEcCtD
Cabergoline—Rash—Niacin—coronary artery disease	5.6e-05	0.000362	CcSEcCtD
Cabergoline—Dermatitis—Niacin—coronary artery disease	5.6e-05	0.000362	CcSEcCtD
Cabergoline—Dizziness—Enalapril—coronary artery disease	5.59e-05	0.000362	CcSEcCtD
Cabergoline—Dyspepsia—Ramipril—coronary artery disease	5.58e-05	0.00036	CcSEcCtD
Cabergoline—Pruritus—Perindopril—coronary artery disease	5.57e-05	0.00036	CcSEcCtD
Cabergoline—Headache—Niacin—coronary artery disease	5.57e-05	0.00036	CcSEcCtD
Cabergoline—Paraesthesia—Timolol—coronary artery disease	5.56e-05	0.000359	CcSEcCtD
Cabergoline—Vomiting—Pravastatin—coronary artery disease	5.56e-05	0.000359	CcSEcCtD
Cabergoline—Hyperhidrosis—Lisinopril—coronary artery disease	5.56e-05	0.000359	CcSEcCtD
Cabergoline—Diarrhoea—Captopril—coronary artery disease	5.55e-05	0.000359	CcSEcCtD
Cabergoline—Dyspnoea—Timolol—coronary artery disease	5.52e-05	0.000357	CcSEcCtD
Cabergoline—Dizziness—Telmisartan—coronary artery disease	5.52e-05	0.000357	CcSEcCtD
Cabergoline—Rash—Pravastatin—coronary artery disease	5.52e-05	0.000356	CcSEcCtD
Cabergoline—Dermatitis—Pravastatin—coronary artery disease	5.51e-05	0.000356	CcSEcCtD
Cabergoline—Decreased appetite—Ramipril—coronary artery disease	5.51e-05	0.000356	CcSEcCtD
Cabergoline—Somnolence—Timolol—coronary artery disease	5.51e-05	0.000356	CcSEcCtD
Cabergoline—Asthenia—Furosemide—coronary artery disease	5.49e-05	0.000355	CcSEcCtD
Cabergoline—Headache—Pravastatin—coronary artery disease	5.48e-05	0.000354	CcSEcCtD
Cabergoline—Anorexia—Lisinopril—coronary artery disease	5.48e-05	0.000354	CcSEcCtD
Cabergoline—Fatigue—Ramipril—coronary artery disease	5.46e-05	0.000353	CcSEcCtD
Cabergoline—Dyspepsia—Timolol—coronary artery disease	5.45e-05	0.000352	CcSEcCtD
Cabergoline—Hypersensitivity—Losartan—coronary artery disease	5.44e-05	0.000352	CcSEcCtD
Cabergoline—Nausea—Valsartan—coronary artery disease	5.43e-05	0.000351	CcSEcCtD
Cabergoline—Pruritus—Furosemide—coronary artery disease	5.42e-05	0.00035	CcSEcCtD
Cabergoline—Constipation—Ramipril—coronary artery disease	5.42e-05	0.00035	CcSEcCtD
Cabergoline—Nausea—Olmesartan—coronary artery disease	5.4e-05	0.000349	CcSEcCtD
Cabergoline—Vomiting—Trandolapril—coronary artery disease	5.4e-05	0.000349	CcSEcCtD
Cabergoline—Diarrhoea—Perindopril—coronary artery disease	5.39e-05	0.000348	CcSEcCtD
Cabergoline—Decreased appetite—Timolol—coronary artery disease	5.38e-05	0.000348	CcSEcCtD
Cabergoline—Vomiting—Enalapril—coronary artery disease	5.38e-05	0.000348	CcSEcCtD
Cabergoline—Hypotension—Lisinopril—coronary artery disease	5.37e-05	0.000347	CcSEcCtD
Cabergoline—Dizziness—Captopril—coronary artery disease	5.37e-05	0.000347	CcSEcCtD
Cabergoline—Rash—Trandolapril—coronary artery disease	5.36e-05	0.000346	CcSEcCtD
Cabergoline—Dermatitis—Trandolapril—coronary artery disease	5.35e-05	0.000346	CcSEcCtD
Cabergoline—Fatigue—Timolol—coronary artery disease	5.34e-05	0.000345	CcSEcCtD
Cabergoline—Rash—Enalapril—coronary artery disease	5.33e-05	0.000345	CcSEcCtD
Cabergoline—Dermatitis—Enalapril—coronary artery disease	5.33e-05	0.000344	CcSEcCtD
Cabergoline—Headache—Trandolapril—coronary artery disease	5.32e-05	0.000344	CcSEcCtD
Cabergoline—Vomiting—Telmisartan—coronary artery disease	5.31e-05	0.000343	CcSEcCtD
Cabergoline—Asthenia—Losartan—coronary artery disease	5.3e-05	0.000343	CcSEcCtD
Cabergoline—Headache—Enalapril—coronary artery disease	5.3e-05	0.000343	CcSEcCtD
Cabergoline—Pain—Timolol—coronary artery disease	5.3e-05	0.000342	CcSEcCtD
Cabergoline—Nausea—Niacin—coronary artery disease	5.28e-05	0.000341	CcSEcCtD
Cabergoline—Rash—Telmisartan—coronary artery disease	5.26e-05	0.00034	CcSEcCtD
Cabergoline—Dermatitis—Telmisartan—coronary artery disease	5.26e-05	0.00034	CcSEcCtD
Cabergoline—Diarrhoea—Furosemide—coronary artery disease	5.24e-05	0.000339	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.24e-05	0.000338	CcSEcCtD
Cabergoline—Pruritus—Losartan—coronary artery disease	5.23e-05	0.000338	CcSEcCtD
Cabergoline—Headache—Telmisartan—coronary artery disease	5.23e-05	0.000338	CcSEcCtD
Cabergoline—Feeling abnormal—Ramipril—coronary artery disease	5.22e-05	0.000337	CcSEcCtD
Cabergoline—Dizziness—Perindopril—coronary artery disease	5.21e-05	0.000337	CcSEcCtD
Cabergoline—Insomnia—Lisinopril—coronary artery disease	5.2e-05	0.000336	CcSEcCtD
Cabergoline—Nausea—Pravastatin—coronary artery disease	5.2e-05	0.000336	CcSEcCtD
Cabergoline—Gastrointestinal pain—Ramipril—coronary artery disease	5.18e-05	0.000335	CcSEcCtD
Cabergoline—Paraesthesia—Lisinopril—coronary artery disease	5.16e-05	0.000333	CcSEcCtD
Cabergoline—Vomiting—Captopril—coronary artery disease	5.16e-05	0.000333	CcSEcCtD
Cabergoline—Dyspnoea—Lisinopril—coronary artery disease	5.12e-05	0.000331	CcSEcCtD
Cabergoline—Rash—Captopril—coronary artery disease	5.12e-05	0.000331	CcSEcCtD
Cabergoline—Dermatitis—Captopril—coronary artery disease	5.11e-05	0.00033	CcSEcCtD
Cabergoline—Somnolence—Lisinopril—coronary artery disease	5.11e-05	0.00033	CcSEcCtD
Cabergoline—Feeling abnormal—Timolol—coronary artery disease	5.1e-05	0.00033	CcSEcCtD
Cabergoline—Headache—Captopril—coronary artery disease	5.08e-05	0.000329	CcSEcCtD
Cabergoline—Gastrointestinal pain—Timolol—coronary artery disease	5.07e-05	0.000327	CcSEcCtD
Cabergoline—Dizziness—Furosemide—coronary artery disease	5.06e-05	0.000327	CcSEcCtD
Cabergoline—Dyspepsia—Lisinopril—coronary artery disease	5.06e-05	0.000327	CcSEcCtD
Cabergoline—Diarrhoea—Losartan—coronary artery disease	5.06e-05	0.000327	CcSEcCtD
Cabergoline—Nausea—Trandolapril—coronary artery disease	5.05e-05	0.000326	CcSEcCtD
Cabergoline—Nausea—Enalapril—coronary artery disease	5.03e-05	0.000325	CcSEcCtD
Cabergoline—Vomiting—Perindopril—coronary artery disease	5.01e-05	0.000324	CcSEcCtD
Cabergoline—Abdominal pain—Ramipril—coronary artery disease	5.01e-05	0.000324	CcSEcCtD
Cabergoline—Decreased appetite—Lisinopril—coronary artery disease	5e-05	0.000323	CcSEcCtD
Cabergoline—Rash—Perindopril—coronary artery disease	4.97e-05	0.000321	CcSEcCtD
Cabergoline—Dermatitis—Perindopril—coronary artery disease	4.96e-05	0.000321	CcSEcCtD
Cabergoline—Nausea—Telmisartan—coronary artery disease	4.96e-05	0.00032	CcSEcCtD
Cabergoline—Fatigue—Lisinopril—coronary artery disease	4.95e-05	0.00032	CcSEcCtD
Cabergoline—Headache—Perindopril—coronary artery disease	4.94e-05	0.000319	CcSEcCtD
Cabergoline—Pain—Lisinopril—coronary artery disease	4.91e-05	0.000318	CcSEcCtD
Cabergoline—Constipation—Lisinopril—coronary artery disease	4.91e-05	0.000318	CcSEcCtD
Cabergoline—Abdominal pain—Timolol—coronary artery disease	4.9e-05	0.000316	CcSEcCtD
Cabergoline—Dizziness—Losartan—coronary artery disease	4.89e-05	0.000316	CcSEcCtD
Cabergoline—Vomiting—Furosemide—coronary artery disease	4.87e-05	0.000315	CcSEcCtD
Cabergoline—Rash—Furosemide—coronary artery disease	4.83e-05	0.000312	CcSEcCtD
Cabergoline—Dermatitis—Furosemide—coronary artery disease	4.82e-05	0.000312	CcSEcCtD
Cabergoline—Nausea—Captopril—coronary artery disease	4.82e-05	0.000312	CcSEcCtD
Cabergoline—Headache—Furosemide—coronary artery disease	4.8e-05	0.00031	CcSEcCtD
Cabergoline—Feeling abnormal—Lisinopril—coronary artery disease	4.74e-05	0.000306	CcSEcCtD
Cabergoline—Gastrointestinal pain—Lisinopril—coronary artery disease	4.7e-05	0.000304	CcSEcCtD
Cabergoline—Vomiting—Losartan—coronary artery disease	4.7e-05	0.000304	CcSEcCtD
Cabergoline—Nausea—Perindopril—coronary artery disease	4.68e-05	0.000302	CcSEcCtD
Cabergoline—Hypersensitivity—Ramipril—coronary artery disease	4.67e-05	0.000302	CcSEcCtD
Cabergoline—Rash—Losartan—coronary artery disease	4.66e-05	0.000301	CcSEcCtD
Cabergoline—Dermatitis—Losartan—coronary artery disease	4.65e-05	0.000301	CcSEcCtD
Cabergoline—Headache—Losartan—coronary artery disease	4.63e-05	0.000299	CcSEcCtD
Cabergoline—Hypersensitivity—Timolol—coronary artery disease	4.56e-05	0.000295	CcSEcCtD
Cabergoline—Nausea—Furosemide—coronary artery disease	4.55e-05	0.000294	CcSEcCtD
Cabergoline—Asthenia—Ramipril—coronary artery disease	4.55e-05	0.000294	CcSEcCtD
Cabergoline—Abdominal pain—Lisinopril—coronary artery disease	4.54e-05	0.000294	CcSEcCtD
Cabergoline—Pruritus—Ramipril—coronary artery disease	4.48e-05	0.00029	CcSEcCtD
Cabergoline—Asthenia—Timolol—coronary artery disease	4.44e-05	0.000287	CcSEcCtD
Cabergoline—Nausea—Losartan—coronary artery disease	4.39e-05	0.000284	CcSEcCtD
Cabergoline—Pruritus—Timolol—coronary artery disease	4.38e-05	0.000283	CcSEcCtD
Cabergoline—Diarrhoea—Ramipril—coronary artery disease	4.34e-05	0.00028	CcSEcCtD
Cabergoline—Diarrhoea—Timolol—coronary artery disease	4.24e-05	0.000274	CcSEcCtD
Cabergoline—Hypersensitivity—Lisinopril—coronary artery disease	4.23e-05	0.000274	CcSEcCtD
Cabergoline—Dizziness—Ramipril—coronary artery disease	4.19e-05	0.000271	CcSEcCtD
Cabergoline—Asthenia—Lisinopril—coronary artery disease	4.12e-05	0.000266	CcSEcCtD
Cabergoline—Dizziness—Timolol—coronary artery disease	4.1e-05	0.000265	CcSEcCtD
Cabergoline—Pruritus—Lisinopril—coronary artery disease	4.07e-05	0.000263	CcSEcCtD
Cabergoline—Vomiting—Ramipril—coronary artery disease	4.03e-05	0.00026	CcSEcCtD
Cabergoline—Rash—Ramipril—coronary artery disease	4e-05	0.000258	CcSEcCtD
Cabergoline—Dermatitis—Ramipril—coronary artery disease	3.99e-05	0.000258	CcSEcCtD
Cabergoline—Headache—Ramipril—coronary artery disease	3.97e-05	0.000257	CcSEcCtD
Cabergoline—Vomiting—Timolol—coronary artery disease	3.94e-05	0.000255	CcSEcCtD
Cabergoline—Diarrhoea—Lisinopril—coronary artery disease	3.93e-05	0.000254	CcSEcCtD
Cabergoline—Rash—Timolol—coronary artery disease	3.91e-05	0.000252	CcSEcCtD
Cabergoline—Dermatitis—Timolol—coronary artery disease	3.9e-05	0.000252	CcSEcCtD
Cabergoline—Headache—Timolol—coronary artery disease	3.88e-05	0.000251	CcSEcCtD
Cabergoline—Dizziness—Lisinopril—coronary artery disease	3.8e-05	0.000246	CcSEcCtD
Cabergoline—Nausea—Ramipril—coronary artery disease	3.76e-05	0.000243	CcSEcCtD
Cabergoline—Nausea—Timolol—coronary artery disease	3.68e-05	0.000238	CcSEcCtD
Cabergoline—Vomiting—Lisinopril—coronary artery disease	3.65e-05	0.000236	CcSEcCtD
Cabergoline—Rash—Lisinopril—coronary artery disease	3.62e-05	0.000234	CcSEcCtD
Cabergoline—Dermatitis—Lisinopril—coronary artery disease	3.62e-05	0.000234	CcSEcCtD
Cabergoline—Headache—Lisinopril—coronary artery disease	3.6e-05	0.000233	CcSEcCtD
Cabergoline—Nausea—Lisinopril—coronary artery disease	3.41e-05	0.000221	CcSEcCtD
Cabergoline—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	1.18e-06	9.79e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	1.17e-06	9.78e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	1.17e-06	9.78e-06	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.17e-06	9.77e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—AKT1—coronary artery disease	1.17e-06	9.75e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	1.17e-06	9.75e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—POMC—coronary artery disease	1.17e-06	9.71e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	1.17e-06	9.71e-06	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	1.16e-06	9.65e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	1.16e-06	9.62e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—AKT1—coronary artery disease	1.16e-06	9.62e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TGFB1—coronary artery disease	1.16e-06	9.62e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—FGF2—coronary artery disease	1.15e-06	9.59e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—VEGFA—coronary artery disease	1.15e-06	9.57e-06	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	1.15e-06	9.57e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CASP3—coronary artery disease	1.15e-06	9.57e-06	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.15e-06	9.56e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	1.15e-06	9.56e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	1.15e-06	9.55e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	1.15e-06	9.55e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	1.14e-06	9.51e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—IL6—coronary artery disease	1.14e-06	9.5e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	1.14e-06	9.5e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	1.14e-06	9.48e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	1.14e-06	9.47e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—NOS3—coronary artery disease	1.14e-06	9.46e-06	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	1.13e-06	9.44e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.13e-06	9.44e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—MAPK1—coronary artery disease	1.13e-06	9.43e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	1.13e-06	9.42e-06	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—IL6—coronary artery disease	1.13e-06	9.4e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	1.13e-06	9.37e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CASP3—coronary artery disease	1.12e-06	9.36e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	1.12e-06	9.35e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	1.12e-06	9.34e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CCND1—coronary artery disease	1.12e-06	9.31e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.12e-06	9.31e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	1.12e-06	9.3e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—IL6—coronary artery disease	1.12e-06	9.3e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PTGS2—coronary artery disease	1.11e-06	9.26e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	1.11e-06	9.25e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	1.11e-06	9.24e-06	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	1.11e-06	9.23e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	1.11e-06	9.23e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TGFB1—coronary artery disease	1.11e-06	9.21e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.1e-06	9.2e-06	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	1.1e-06	9.19e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	1.1e-06	9.17e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CASP3—coronary artery disease	1.1e-06	9.15e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	1.1e-06	9.12e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CCND1—coronary artery disease	1.09e-06	9.11e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	1.09e-06	9.1e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CASP3—coronary artery disease	1.09e-06	9.1e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—IL6—coronary artery disease	1.09e-06	9.09e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.09e-06	9.05e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—IL6—coronary artery disease	1.09e-06	9.04e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MMP9—coronary artery disease	1.09e-06	9.04e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.09e-06	9.04e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—VEGFA—coronary artery disease	1.08e-06	9.03e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—MAPK1—coronary artery disease	1.08e-06	9.03e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.08e-06	9.01e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	1.08e-06	8.96e-06	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	1.07e-06	8.94e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—VEGFA—coronary artery disease	1.07e-06	8.91e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	1.07e-06	8.91e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CCND1—coronary artery disease	1.07e-06	8.91e-06	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.07e-06	8.88e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	1.07e-06	8.87e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.07e-06	8.87e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	1.06e-06	8.86e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CCND1—coronary artery disease	1.06e-06	8.86e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	1.06e-06	8.85e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MMP9—coronary artery disease	1.06e-06	8.84e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	1.06e-06	8.8e-06	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	1.06e-06	8.79e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	1.06e-06	8.79e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	1.05e-06	8.77e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.05e-06	8.76e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	1.05e-06	8.71e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	1.04e-06	8.69e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.04e-06	8.68e-06	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—AKT1—coronary artery disease	1.04e-06	8.67e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	1.04e-06	8.66e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MMP9—coronary artery disease	1.04e-06	8.65e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	1.04e-06	8.62e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	1.04e-06	8.62e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MMP9—coronary artery disease	1.03e-06	8.6e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	1.03e-06	8.59e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	1.03e-06	8.58e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GGT1—coronary artery disease	1.02e-06	8.48e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GOT1—coronary artery disease	1.02e-06	8.48e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	1.02e-06	8.48e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	1.02e-06	8.47e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CXCL8—coronary artery disease	1.01e-06	8.39e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	1.01e-06	8.39e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	1.01e-06	8.37e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	1e-06	8.34e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TGFB1—coronary artery disease	9.95e-07	8.29e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	9.92e-07	8.26e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	9.89e-07	8.23e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	9.89e-07	8.23e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	9.83e-07	8.18e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TGFB1—coronary artery disease	9.82e-07	8.18e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	9.82e-07	8.18e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	9.77e-07	8.13e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MAPK1—coronary artery disease	9.76e-07	8.13e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	9.75e-07	8.12e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	9.75e-07	8.11e-06	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	9.74e-07	8.11e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	9.71e-07	8.09e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	9.69e-07	8.07e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	9.66e-07	8.04e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CASP3—coronary artery disease	9.65e-07	8.03e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	9.63e-07	8.02e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MAPK1—coronary artery disease	9.63e-07	8.02e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	9.59e-07	7.99e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—IL6—coronary artery disease	9.59e-07	7.98e-06	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	9.58e-07	7.98e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	9.56e-07	7.96e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	9.54e-07	7.94e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CASP3—coronary artery disease	9.5e-07	7.9e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL6—coronary artery disease	9.43e-07	7.85e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	9.41e-07	7.83e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CCND1—coronary artery disease	9.39e-07	7.82e-06	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	9.38e-07	7.81e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	9.33e-07	7.76e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	9.3e-07	7.74e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	9.28e-07	7.72e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CCND1—coronary artery disease	9.24e-07	7.69e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	9.24e-07	7.69e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GSTP1—coronary artery disease	9.15e-07	7.62e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MMP9—coronary artery disease	9.12e-07	7.59e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	9.07e-07	7.55e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	9.05e-07	7.53e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—HMOX1—coronary artery disease	9.03e-07	7.51e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	9.03e-07	7.51e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	9.02e-07	7.51e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	8.98e-07	7.48e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MMP9—coronary artery disease	8.97e-07	7.47e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	8.95e-07	7.45e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CAT—coronary artery disease	8.91e-07	7.41e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	8.88e-07	7.39e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	8.87e-07	7.38e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—AKT1—coronary artery disease	8.84e-07	7.36e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	8.79e-07	7.31e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	8.78e-07	7.31e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	8.75e-07	7.29e-06	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	8.72e-07	7.26e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL6—coronary artery disease	8.7e-07	7.25e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	8.7e-07	7.24e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	8.7e-07	7.24e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL6—coronary artery disease	8.65e-07	7.2e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOB—coronary artery disease	8.65e-07	7.2e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	8.64e-07	7.19e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	8.59e-07	7.15e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	8.58e-07	7.14e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	8.56e-07	7.13e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	8.52e-07	7.09e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	8.52e-07	7.09e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	8.47e-07	7.05e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL6—coronary artery disease	8.47e-07	7.05e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—PIK3CA—coronary artery disease	8.43e-07	7.02e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GSTM1—coronary artery disease	8.41e-07	7e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	8.41e-07	7e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	8.39e-07	6.99e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	8.36e-07	6.96e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	8.36e-07	6.96e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	8.35e-07	6.95e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL6—coronary artery disease	8.33e-07	6.94e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	8.28e-07	6.9e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—LPL—coronary artery disease	8.26e-07	6.87e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—VEGFA—coronary artery disease	8.19e-07	6.82e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	8.16e-07	6.8e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	8.15e-07	6.79e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	8.12e-07	6.76e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	8.06e-07	6.71e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GPX1—coronary artery disease	8.05e-07	6.7e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—AKT1—coronary artery disease	8.03e-07	6.69e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	7.99e-07	6.66e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—AKT1—coronary artery disease	7.98e-07	6.64e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL6—coronary artery disease	7.95e-07	6.62e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	7.92e-07	6.59e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	7.89e-07	6.57e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CD36—coronary artery disease	7.84e-07	6.53e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—AKT1—coronary artery disease	7.81e-07	6.5e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPP2CA—coronary artery disease	7.75e-07	6.45e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—AKT1—coronary artery disease	7.69e-07	6.4e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	7.62e-07	6.34e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	7.55e-07	6.28e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TGFB1—coronary artery disease	7.52e-07	6.26e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL6—coronary artery disease	7.5e-07	6.24e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	7.45e-07	6.2e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MTHFR—coronary artery disease	7.43e-07	6.19e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL6—coronary artery disease	7.4e-07	6.16e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL6—coronary artery disease	7.4e-07	6.16e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	7.4e-07	6.16e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MAPK1—coronary artery disease	7.37e-07	6.14e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—AKT1—coronary artery disease	7.34e-07	6.11e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	7.33e-07	6.1e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	7.28e-07	6.06e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	7.25e-07	6.04e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	7.25e-07	6.03e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	7.24e-07	6.03e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	7.1e-07	5.91e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AGT—coronary artery disease	7.06e-07	5.88e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	7.05e-07	5.87e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	6.94e-07	5.78e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—AKT1—coronary artery disease	6.92e-07	5.76e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOE—coronary artery disease	6.92e-07	5.76e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—AKT1—coronary artery disease	6.89e-07	5.73e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PIK3CA—coronary artery disease	6.85e-07	5.7e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOA1—coronary artery disease	6.84e-07	5.69e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—AKT1—coronary artery disease	6.83e-07	5.68e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	6.83e-07	5.68e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL6—coronary artery disease	6.74e-07	5.61e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	6.73e-07	5.6e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL6—coronary artery disease	6.68e-07	5.56e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	6.6e-07	5.49e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL6—coronary artery disease	6.6e-07	5.49e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL6—coronary artery disease	6.45e-07	5.37e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL6—coronary artery disease	6.42e-07	5.34e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	6.4e-07	5.32e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	6.29e-07	5.24e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL6—coronary artery disease	6.24e-07	5.2e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—AKT1—coronary artery disease	6.22e-07	5.18e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	6.16e-07	5.13e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	6.16e-07	5.13e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL6—coronary artery disease	6.14e-07	5.11e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—AKT1—coronary artery disease	6.09e-07	5.07e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARG—coronary artery disease	6.03e-07	5.02e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—AKT1—coronary artery disease	5.95e-07	4.95e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—POMC—coronary artery disease	5.94e-07	4.95e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—AKT1—coronary artery disease	5.92e-07	4.93e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	5.76e-07	4.79e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	5.73e-07	4.77e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	5.67e-07	4.72e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL6—coronary artery disease	5.66e-07	4.71e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—AKT1—coronary artery disease	5.59e-07	4.66e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL6—coronary artery disease	5.57e-07	4.64e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL6—coronary artery disease	5.46e-07	4.54e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ALB—coronary artery disease	5.42e-07	4.51e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—AKT1—coronary artery disease	5.22e-07	4.35e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—NOS3—coronary artery disease	5.18e-07	4.32e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—AKT1—coronary artery disease	5.14e-07	4.28e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6—coronary artery disease	5.07e-07	4.22e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	5.03e-07	4.19e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PTGS2—coronary artery disease	4.74e-07	3.95e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	4.68e-07	3.89e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.92e-07	2.43e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AKT1—coronary artery disease	2.38e-07	1.98e-06	CbGpPWpGaD
